Celyad Oncology

Rue Edouard Belin 12
1435 Mont-Saint-Guibert
BE
Celyad Oncology
Foundation date
24 July 2007
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
Celyad Oncology is a biotechnology company focused on the discovery and development of CAR T therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.
Upcoming events
All events-
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB -
1212 '23
BioFIT 2023
Event by: Eurasanté
Latest news
More news-
argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis
Thursday September 21st 2023
Read more
-
Galapagos appoints Simon Sturge to its Board of Directors
Tuesday September 19th 2023
Read more
-
13th Investment for HERAN Partners: Broken String Biosciences (UK)
Tuesday September 19th 2023
Read more
Jobs
More jobs-
23/09/23
East Flanders
ERC-funded postdoc position on inter-organelle communication during plant biotic stress responses
Permanent
VIB -
21/09/23
East Flanders
Technician Protein Production and Characterization
Permanent
Orionis Biosciences -
20/09/23
Flemish Brabant
Lab Technician in the Lab for Tumor Inflammation and Angiogenesis
Permanent
VIB